FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to hepatology, and can be used for screening of patients suspected of liver disease. To this end, 13C-metacetin respiratory test. If the cumulative dose value 13C the specified test at 30th minute <5.65 % hepatic cirrhosis is determined.
EFFECT: method enables non-invasive determination of hepatic cirrhosis, which enables eliminating the risk of developing complications.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING DEGREE OF LIVER FIBROSIS | 2018 |
|
RU2675341C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 |
|
RU2744021C1 |
| METHOD FOR DETERMINING A STAGE OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C | 2019 |
|
RU2722877C1 |
| METHOD FOR MONITORING HEPATIC FIBROSIS CASES IN CHRONIC HEPATITIS C PATIENTS | 2005 |
|
RU2309406C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN MEN | 2020 |
|
RU2753455C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF DIFFUSE DISEASES OF LIVER | 2011 |
|
RU2482792C1 |
| DIAGNOSTIC TECHNIQUE FOR CIRRHOTIC STAGE OF CHRONIC VIRAL HEPATITIS C | 2014 |
|
RU2563129C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATITIS AND HEPATIC CIRRHOSIS | 2012 |
|
RU2516970C1 |
| DIAGNOSTIC TECHNIQUE FOR HEPATIC FIBROSIS ACCOMPANYING VIRAL HEPATITIS C | 2014 |
|
RU2557927C1 |
| SCREENING DIAGNOSING METHOD FOR FATTY LIVER DEGENERATION ACCOMPANYING ABDOMINAL OBESITY | 2018 |
|
RU2684201C1 |
